Next, we selected myeloid cell clusters on the basis of the expression of myeloid cell markers (“CD14+”, “FCER1A-”) by the scGate R package from GSE207422 (LUAD samples) and GSE205506 (CRC tumour samples). This evidence concerns the gene CD14 and colorectal carcinoma.